In vitro and in vivo evidence that thrombospondin-1 (TSP-1) contributes to stirring- and shear-dependent activation of platelet-derived TGF-β1

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Ahamed, Jasimuddin ^a   Janczak, Christin A ^a   Wittkowski, Knut M ^a   Coller, Barry S ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THIOPHENE; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY THROMBOSIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; EOSINOPHIL COUNT; ERYTHROCYTE COUNT; HEMATOCRIT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MEAN CORPUSCULAR VOLUME; MONOCYTE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; SHEAR STRESS; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE RELEASE REACTION; THROMBOCYTE VOLUME; WILD TYPE; ANIMAL; CAROTID ARTERY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; MASS SPECTROMETRY; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; THROMBOCYTE; THROMBOSIS;

MUS;

ANIMALS; BLOOD PLATELETS; CAROTID ARTERIES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; MASS SPECTROMETRY; MICE; MICE, KNOCKOUT; THROMBOSIS; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

EID: 68949162163     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006608     Document Type: Article

References (54)

1. Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358.
2. Li MO, Flavell RA (2008) TGF-beta: a master of all T cell trades. Cell 134: 392-404.
3. Massague J (2008) TGFbeta in Cancer. Cell 134: 215-230.
4. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB (1983) Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258: 7155-7160.
5. Abdelouahed M, Ludlow A, Brunner G, Lawler J (2000) Activation of platelet-transforming growth factor beta-1 in the absence of thrombospondin-1. J Biol Chem 275: 17933-17936.
6. Assoian RK, Sporn MB (1986) Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol 102: 1217-1223.
7. Blakytny R, Ludlow A, Martin GE, Ireland G, Lund LR, et al. (2004) Latent TGF-beta1 activation by platelets. J Cell Physiol 199: 67-76.
8. Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC (1995) Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med 1: 932-937.
9. Schini-Kerth VB, Bassus S, Fisslthaler B, Kirchmaier CM, Busse R (1997) Aggregating human platelets stimulate the expression of thrombin receptors in cultured vascular smooth muscle cells via the release of transforming growth factor-beta1 and platelet-derived growth factorAB. Circulation 96: 3888-3896.
10. Slivka SR, Loskutoff DJ (1991) Platelets stimulate endothelial cells to synthesize type 1 plasminogen activator inhibitor. Evaluation of the role of transforming growth factor beta. Blood 77: 1013-1019.
11. Wakefield LM, Smith DM, Flanders KC, Sporn MB (1988) Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. J Biol Chem 263: 7646-7654.
12. Ahamed J, Burg N, Yoshinaga K, Janczak CA, Rifkin DB, et al. (2008) In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-{beta}1 (TGF-{beta}1). Blood.
13. Annes JP, Munger JS, Rifkin DB (2003) Making sense of latent TGFbeta activation. J Cell Sci 116: 217-224.
14. Annes JP, Chen Y, Munger JS, Rifkin DB (2004) Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J Cell Biol 165: 723-734.
15. Barcellos-Hoff MH, Dix TA (1996) Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol 10: 1077-1083.
16. Lyons RM, Gentry LE, Purchio AF, Moses HL (1990) Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J Cell Biol 110: 1361-1367.
17. Munger JS, Harpel JG, Giancotti FG, Rifkin DB (1998) Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1. Mol Biol Cell 9: 2627-2638.
18. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, et al. (1999) The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328.
19. Murphy-Ullrich JE, Schultz-Cherry S, Hook M (1992) Transforming growth factor-beta complexes with thrombospondin. Mol Biol Cell 3: 181-188.
20. Murphy-Ullrich JE, Poczatek M (2000) Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev 11: 59-69.
21. Schultz-Cherry S, Murphy-Ullrich JE (1993) Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 122: 923-932.
22. Schultz-Cherry S, Lawler J, Murphy-Ullrich JE (1994) The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. J Biol Chem 269: 26783-26788.
23. Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE (1994) Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J Biol Chem 269: 26775-26782.
24. Schultz-Cherry S, Chen H, Mosher DF, Misenheimer TM, Krutzsch HC, Roberts DD, et al. (1995) Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem 270: 7304-7310.
25. Souchelnitskiy S, Chambaz EM, Feige JJ (1995) Thrombospondins selectively activate one of the two latent forms of transforming growth factor-beta present in adrenocortical cell-conditioned medium. Endocrinology 136: 5118-5126.
26. Travis MA, Reizis B, Melton AC, Masteller E, Tang Q, et al. (2007) Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449: 361-365.
27. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, et al. (1998) Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93: 1159-1170.
28. Lawler J, Sunday M, Thibert V, Duquette M, George EL, et al. (1998) Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 101: 982-992.
29. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, et al. (1993) Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 90: 770-774.
30. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, et al. (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
31. Bornstein P (1992) Thrombospondins: structure and regulation of expression. FASEB J 6: 3290-3299.
32. Frazier WA (1987) Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells. J Cell Biol 105: 625-632.
33. Harrison P, Cramer EM (1993) Platelet alpha-granules. Blood Rev 7: 52-62.
34. Lawler J (1986) The structural and functional properties of thrombospondin. Blood 67: 1197-1209.
35. Mosher DF (1990) Physiology of thrombospondin. Annu Rev Med 41: 85-97.
36. Young GD, Murphy-Ullrich JE (2004) The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex. J Biol Chem 279: 47633-47642.
37. Zhou Y, Poczatek MH, Berecek KH, Murphy-Ullrich JE (2006) Thrombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions. Biochem Biophys Res Commun 339: 633-641.
38. Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE (1999) The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 274: 13586-13593.
39. Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, et al. (2005) Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 111: 2935-2942.
40. Grainger DJ, Frow EK (2000) Thrombospondin 1 does not activate transforming growth factor beta1 in a chemically defined system or in smooth-muscle-cell cultures. Biochem J 350 Pt1: 291-298.
41. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB (1994) An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 216: 276-284.
42. Detwiler TC, Turk JL, Browne PC (1987) Thiol-disulfide exchange by thrombospondin. Semin Thromb Hemost 13: 276-280.
43. Huang EM, Detwiler TC, Milev Y, Essex DW (1997) Thiol-disulfide isomerization in thrombospondin: effects of conformation and protein disulfide isomerase. Blood 89: 3205-3212.
44. Turk JL, Detwiler TC (1986) Thiol-disulfide exchange by thrombospondin: evidence for a thiol and a disulfide bond protected by calcium. Arch Biochem Biophys 245: 446-454.
45. Yee KO, Duquette M, Ludlow A, Lawler J (2003) Purification and analysis of thrombospondin-1. Curr Protoc Cell Biol Chapter 10: Unit.
46. Detwiler TC, Charo IF, Feinman RD (1978) Evidence that calcium regulates platelet function. Thromb Haemost 40: 207-211.
47. Choi H, Aboulfatova K, Pownall HJ, Cook R, Dong JF (2007) Shear-induced disulfide bond formation regulates adhesion activity of von willebrand factor. J Biol Chem.
48. Xie L, Chesterman CN, Hogg PJ (2001) Control of von Willebrand factor multimer size by thrombospondin-1. J Exp Med 193: 1341-1349.
49. Grinstein S, Furuya W (1983) The electrochemical H+ gradient of platelet secretory alpha-granules. Contribution of a H+ pump and a Donnan potential. J Biol Chem 258: 7876-7882.
50. Gilbert HF (1995) Thiol/disulfide exchange equilibria and disulfide bond stability. Methods Enzymol 251: 8-28.
51. Shet AS, Hoffmann TJ, Jirouskova M, Janczak CA, Stevens JR, et al. (2008) Morphological and functional platelet abnormalities in Berkeley sickle cell mice. Blood Cells Mol Dis 41: 109-118.
52. Ahamed J, Versteeg HH, Kerver M, Chen VM, Mueller BM, et al. (2006) Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci U S A 103: 13932-13937.
53. Roth DM, Swaney JS, Dalton ND, Gilpin EA, Ross J Jr (2002) Impact of anesthesia on cardiac function during echocardiography in mice. Am J Physiol Heart Circ Physiol 282: H2134-H2140.
54. Jirouskova M, Chereshnev I, Vaananen H, Degen JL, Coller BS (2004) Antibody blockade or mutation of the fibrinogen gamma-chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogen. Blood 103: 1995-2002.